Gossamer Bio
GOSS
GOSS
99 hedge funds and large institutions have $74.4M invested in Gossamer Bio in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 43 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
56% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 43
Holders
99
Holding in Top 10
–
Calls
$1.2M
Puts
$584K
Top Buyers
| 1 | +$4.04M | |
| 2 | +$2.4M | |
| 3 | +$1.31M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.02M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$551K |
Top Sellers
| 1 | -$3.56M | |
| 2 | -$3.46M | |
| 3 | -$2.05M | |
| 4 |
Walleye Capital
New York
|
-$2.03M |
| 5 |
HF
HRT Financial
New York
|
-$1.95M |